go back

Arizona rates for HCPCS C9081

Idecabtagene vicleucel, up to 460 million autologous anti-BCMA CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $436,516 · 10th–90th $426,580–$436,5160%50%100%10th$436,516Professionalmedian $501,187 · 10th–90th $501,187–$630,9570%50%90th$501,187$500.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$426,579.52 / $436,515.83 / $436,515.83
Medica
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$630,957.34 / $630,957.34 / $630,957.34
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$501,187.23 / $501,187.23 / $501,187.23